Page 52

Enero 2017

ARTÍCULO DE INVESTIGACIÓN 48 guideline on optimal and uniform treatment. Neth J Med 2011; 69 (11): 500-7. 21. Savelli BA, Parshley M, Morganroth ML. Success fultreatment of sclerosing cervicitis and fibrosing mediastinitis with tamoxifen. Chest 1997; 111 (4): 1137-40. 22. Hansmann A, Adolph C, Vogel T, Unger A, Moeslein G. Peritonitis esclerosante en diálisis peritoneal - R. Torres et al High-dose tamoxifen and sulindac as first-line treatment fordesmoid tumors. Cancer 2004; 100: 612-20. 23. van Bommel EF, Hendriksz TR, Huiskes AW, Zeegers AG. Brief communication: tamoxifen therapy fornonmalignantretro peritoneal fibrosis. Ann Intern Med 2006; 144: 101-6. 24. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF (beta2) in Dupuytren’s affected palmar fascia. J Surg Res 2002; 103: 146-52. 25. Allaria PM, Giangrande A, Gandini E, Pisoni IB. Continuous ambulatory peritoneal dialysis and sclerosin gen capsulating peritonitis: tamoxifen as a new therapeutic agent? J Nephrol 1999; 12: 395-7. 26. Balasubramaniam G, Brown EA, Davenport A, Cairns H, Cooper B, Fan SL, et al. The Pan-Thames EPS study: treatment and outcomes of encapsulating peritoneal sclerosis. Nephrol Dial Transplant 2009; 24 (10): 3209- 15. 27. Kawanishi H, Moriishi M, Ide K, Dohi K. Recommendation of the surgical option for treatment of encapsulating peritoneal sclerosis. Perit Dial Int 2008; 28 (S3): S205-10. 28. De Freitas D, Jordaan A, Williams R. Nutritional management of patients under going surgery following diagnosis withen capsulating peritoneal sclerosis. Perit Dial Int 2008; 28 (3): 271-6. 29. Kawanishi K, Honda K, Tsukada M, Oda H, Nitta K. Neutral Solution Low in Glucose Degradation Products Is Associated with Less Peritoneal Fibrosis and Vascular Sclerosis in Patients Receiving Peritoneal Dialysis. Perit Dial Int 2013; 33 (3): 242-51. 30. Kawanishi H, Shintaku S, Banshodani M, Hashimoto S. Contribution Nephrology 2015; 185: 87-97. 31. Hendriks MP, De Sévaux RGL, Hilbrands LB. Encapsulating peritoneal sclerosis in patientson peritoneal dialysis. Neth J Med 2008; 66 (7): 269-74. 32. Zhou Q, Bajo MA, Del Peso G, Yu X, Selgas R. Preventing peritoneal membrane fibrosis in peritoneal dialysis patients. Kidney Int 2016; 90 (3): 515-24. 33. Registro de diálisis XXXII. Cuenta de hemodiálisis y peritoneodiálisis crónica en Chile (al 31 de agosto de 2013) Dr. Hugo Poblete Badal. http://www.nefro.cl/ phocadownload/registros/hemodialisis/HDC2013.pdf Rev Med Chile 2017; 145: 41-48


Enero 2017
To see the actual publication please follow the link above